MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fneur.2025.1635618

Медицинская библиотека · Frontiers in neurology · 2025

Predictors of therapy switching to high-efficacy disease-modifying therapies in patients with multiple sclerosis: a single center, retrospective, observational study.

Makarevičius Gytis, Kizlaitienė Rasa, Kaubrys Gintaras, Giedraitienė Nataša

СтатьяПеревод в очереди

Аннотация

OBJECT: The treatment of multiple sclerosis (MS) with high-efficacy disease-modifying therapies (HE-DMTs) may lead to better long-term outcomes for patients. There is an ongoing debate about which patients should initially start with these treatments. The objective of this study was to assess the first symptoms at the time of MS diagnosis and to identify independent predictors of treatment switching to HE-DMTs in MS patients within 5 years after diagnosis.

MATERIALS AND

METHODS

A single-center retrospective, observational study was conducted at tertiary MS center Vilnius University Hospital Santaros Klinikos, Lithuania. 319 patients newly diagnosed with relapsing MS who were initially treated with MS platform therapy between 2010 and 2019 were included.

RESULTS

During the disease course, 26.65% of patients were switched from platform therapy to HE-DMTs within 5 years of follow-up. Factors associated with the need to switch therapies were younger age (p < 0.001), shorter disease duration (p < 0.001) and higher progression index (p < 0.001) at diagnosis, lower initial EDSS (p = 0.003) and the presence of cerebellum and/or brainstem symptoms (p = 0.047). Younger age, shorter disease duration and cerebellar/brainstem presentation at diagnosis remained statistically significant after logistic regression analysis.

CONCLUSION

Younger age, shorter disease duration and cerebellar/brainstem presentation at diagnosis were consistently associated with the need to escalate platform.

Для цитирования: Makarevičius Gytis, Kizlaitienė Rasa, Kaubrys Gintaras, Giedraitienė Nataša. Predictors of therapy switching to high-efficacy disease-modifying therapies in patients with multiple sclerosis: a single center, retrospective, observational study.. Frontiers in neurology. 2025. DOI: 10.3389/fneur.2025.1635618.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.